A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer-Reference-Cited by-同舟云学术

A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer

Published:2021-05-05 Issue:16 Volume:127 Page:2954-2965
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

George Daniel J.¹²,Halabi Susan²³,Heath Elisabeth I.⁴,Sartor A. Oliver⁵^ORCID,Sonpavde Guru P.⁶,Das Devika⁶,Bitting Rhonda L.⁷,Berry William¹²,Healy Patrick²,Anand Monika²^ORCID,Winters Carol²,Riggan Colleen²,Kephart Julie²,Wilder Rhonda²,Shobe Kellie²,Rasmussen Julia²,Milowsky Matthew I.⁸^ORCID,Fleming Mark T.⁹,Bearden James¹⁰,Goodman Michael¹¹,Zhang Tian¹²^ORCID,Harrison Michael R.¹²,McNamara Megan¹²,Zhang Dadong¹²,LaCroix Bonnie L.²,Kittles Rick A.¹³,Patierno Brendon M.²,Sibley Alexander B.¹²,Patierno Steven R.¹²,Owzar Kouros³¹²,Hyslop Terry²³,Freedman Jennifer A.¹²,Armstrong Andrew J.¹²^ORCID

Affiliation:

1. Department of Medicine, Division of Medical Oncology Duke University Durham North Carolina

2. Center for Prostate and Urologic Cancers Duke Cancer Institute Duke University Durham North Carolina

3. Department of Biostatistics and Bioinformatics Duke University School of Medicine Durham North Carolina

4. Karmanos Cancer InstituteWayne State University Detroit Michigan

5. Tulane Cancer Center Tulane Health Sciences Center New Orleans Louisiana

6. Hematology and Oncology Division Birmingham Veterans Affairs Medical Center Birmingham Alabama

7. Comprehensive Cancer Center Wake Forest University Winston Salem North Carolina

8. Department of Medicine Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill Chapel Hill North Carolina

9. Virginia Oncology Associates Hampton Virginia

10. Gibbs Cancer Center Spartanburg South Carolina

11. W.G. (Bill) Hefner VA Medical Center Salisbury North Carolina

12. Duke Cancer Institute Duke University School of Medicine Durham North Carolina

13. Department of Population Sciences Division of Health Equities City of Hope National Medical Center Duarte California

Funder

Janssen Pharmaceuticals

Prostate Cancer Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33589

Reference55 articles.

1. Surveillance Epidemiology and End Results (SEER) Program;National Cancer Institute.Overview of the SEER Program. Accessed January 4 2021.https://seer.cancer.gov/index.html

2. Racial Differences in the Diagnosis and Treatment of Prostate Cancer

3. Pain Predicts Overall Survival in Men With Metastatic Castration-Refractory Prostate Cancer

4. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

5. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nature and nurture: addressable causes of disparities in prostate cancer care and survivorship in Black men;Expert Review of Anticancer Therapy;2024-08-30

2. Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes;JAMA Network Open;2024-03-20

3. Evaluation of Survival Outcomes Among Black and White Patients with Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Open Science;2024-03

4. The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men;Nature Reviews Urology;2024-02-02

5. Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?;Journal of Clinical Oncology;2024-01-10